There is a difference between ferrous succinate tablets and extended-release tablets in terms of dosage form, with the latter having a higher bioavailability, and the specific dosage should be in accordance with the doctor’s instructions.
Ferrous Succinate Tablets and Extended-Release Tablets can be used for the prevention and treatment of iron deficiency anemia, the main difference between the two is the difference in dosage form, the former belongs to the tablets, while the latter belongs to the extended-release tablets, in contrast, the latter into the digestive tract after the release of the slower speed than the former, and the bio-availability of higher.
Contraindications to the use of the drug include persons with non-iron deficiency anemia, hypersensitivity to the product, severe hepatic or renal impairment (especially if accompanied by untreated urinary tract infections), excessive iron loading, and patients with a diagnosis of hemochromatosis or ferrous hemosiderosis.
A diagnosis of iron deficiency anemia is required prior to dosing, and blood and serum iron levels should be checked periodically after dosing. Gastrointestinal adverse reactions such as epigastric pain, constipation, nausea and vomiting may occur during administration. Specific use of the drug should be carried out under the guidance of a specialist, not unauthorized use of drugs.